Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olfactory Mucosa-derived MSCs for Allergic Rhinitis and Chronic Rhinosinusitis
NCT05167552Phase 2Unknown
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of olfactory mucosa-derived mesenchymal stem cells in allergic rhinitis (AR), chronic rhinosinusitis with nasal polyps (CRSwNP). Status: unknown.
02
Drugs
olfactory mucosa-derived mesenchymal stem cells
03
Conditions
allergic rhinitis (AR)chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05167552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05167552.